Ftse Mib
33.641,96
-0,28%
DAX
18.001,60
0,54%
S&P 500
5.128,85
1,28%
NASDAQ
16.157,85
2,00%
Bitcoin
61.952,78
4,79%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PROCEPT BioRobotics Corporation (PRCT) PROCEPT BioRobotics Corporation (PRCT) Notizie

PROCEPT BioRobotics Corporation

PRCT
63,12
1,38 (2,24%)
Ultimo aggiornamento: 19:26:27
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202413:00GLOBEPROCEPT BioRobotics Reports First Quarter 2024 Financial..
29/4/202414:00GLOBELate Breaking Abstract Presented at the Japanese Urological..
23/4/202414:00GLOBEPROCEPT BioRobotics Announces 12 Scientific Research..
04/4/202422:04GLOBEPROCEPT BioRobotics Corp. Announces Investor Event at 2024..
02/4/202422:03GLOBEPROCEPT BioRobotics to Report First Quarter 2024 Financial..
08/3/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:07EDGAR2Form 8-K - Current report
27/2/202422:02GLOBEPROCEPT BioRobotics Reports Fourth Quarter and Full Year..
13/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05GLOBEPROCEPT BioRobotics to Present at the 44th Annual TD Cowen..
09/2/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:30GLOBECTS Corporation Announces Appointment of Amy M. Dodrill to..
08/2/202401:50EDGAR2Form 144 - Report of proposed sale of securities
08/2/202401:49EDGAR2Form 144 - Report of proposed sale of securities
11/1/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:00GLOBEPROCEPT BioRobotics® Announces Preliminary Fourth Quarter..
16/12/202300:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202302:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202302:01EDGAR2Form 3/A - Initial statement of beneficial ownership of..
08/12/202323:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202301:27EDGAR2Form 144 - Report of proposed sale of securities
07/12/202301:05EDGAR2Form 144 - Report of proposed sale of securities
14/11/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202300:29EDGAR2Form 144 - Report of proposed sale of securities
13/11/202322:03GLOBEPROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper..
02/11/202321:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:10EDGAR2Form 8-K - Current report
01/11/202321:02GLOBEPROCEPT BioRobotics® Reports Third Quarter 2023 Financial..
18/10/202322:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202322:05GLOBEPROCEPT BioRobotics to Report Third Quarter 2023 Financial..
12/10/202314:00GLOBEThe National Institute for Health and Care Excellence..
20/9/202314:00GLOBEPROCEPT BioRobotics Announces New Corporate Headquarters in..
12/9/202322:11EDGAR2Form 8-K - Current report
12/9/202314:00GLOBEPROCEPT BioRobotics® Receives U.S. FDA Investigational..
22/8/202314:00GLOBEPROCEPT BioRobotics® Announces First Commercial Aquablation..
17/8/202322:05GLOBEPROCEPT BioRobotics to Present at the 2023 Wells Fargo..
16/8/202314:00GLOBENorthShore University HealthSystem offers expanded access to..
04/8/202322:01EDGAR2Form 8-K - Current report
03/8/202322:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/8/202304:10GLOBEPROCEPT BioRobotics Corporation Announces Pricing of Upsized..
01/8/202322:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
01/8/202322:06GLOBEPROCEPT BioRobotics Corporation Announces Proposed Offering..
01/8/202322:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
31/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 62,95 Min: 60,67 Max: 64,19
Chiusura: 61,74

La tua Cronologia

NASDAQ
PRCT
PROCEPT BioRobotics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network